University of Wisconsin-Madison Carbone Cancer Center

Madison, Wisconsin 53706

1 studies enrolling now · 2 studies all time

What they study most

HER2-low Hormone Receptor Positive Breast Cancer, Melanoma (Skin Cancer), Prostate Neoplasms

Studies at this site

• Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors — Recruiting now
• A Study to Determine the Maximum Tolerated Dose of ASG-5ME in Subjects With Castration-Resistant Prostate Cancer — Completed